Recent studies demonstrated NDRG1 was a potent growth and metastasis suppressor in multiple cancers.[42, 43] In our LM samples, the phosphorylation level of NDRG1 Ser330 (NDRG1 S330p) was positively correlated with actin cytoskeleton reorganization (ρ = 0.43, p = 0.013, Spearman correlation analysis) and actin filament‐based movement (ρ = 0.34, p = 0.053) (Figure S4C, Supporting Information). The gene discussed is NDRG1; the disease is lymphangioma.